Adviser Profile
|
Exempt Reporting Adviser
2B(3)- PF>150mn
|
|
| Private Fund GAV* | 0 |
| SMA’s | No |
| Private Funds | 0 1 |
Private Funds
Employees
Top Holdings
| Stock Ticker | Stock Name | $ Position | % Position | $ Change | # Change |
|---|---|---|---|---|---|
| Stck Ticker252828108 | Stock NameDIANTHUS THERAPEUTICS INC | $ Position$205,115,856 | % Position33.00% | $ Change16.00% | # Change0.00% |
| Stck Ticker156944100 | Stock NameCG ONCOLOGY INC | $ Position$99,395,255 | % Position16.00% | $ Change14.00% | # Change9.00% |
| Stck Ticker687604108 | Stock NameORUKA THERAPEUTICS INC | $ Position$72,369,552 | % Position12.00% | $ Change94.00% | # Change0.00% |
| Stck Ticker008064206 | Stock NameJADE BIOSCIENCES INC | $ Position$37,789,732 | % Position6.00% | $ Change11.00% | # Change21.00% |
| Stck Ticker29337E102 | Stock NameENLIVEN THERAPEUTICS INC | $ Position$27,912,500 | % Position4.00% | $ Change69.00% | # Change38.00% |
| Stck Ticker46489V302 | Stock NamePERSPECTIVE THERAPEUTICS INC | $ Position$21,482,997 | % Position3.00% | $ Change-9.00% | # Change4.00% |
| Stck Ticker697947109 | Stock NamePALVELLA THERAPEUTICS INC NE | $ Position$10,697,400 | % Position2.00% | $ Change23.00% | # Change0.00% |
| Stck Ticker759916109 | Stock NameREPLIGEN CORP | $ Position$10,615,032 | % Position2.00% | $ Change15.00% | # Change0.00% |
| Stck Ticker4525EP200 | Stock NameIMMUNIC INC | $ Position$10,296,993 | % Position2.00% | $ Change | # Change |
| Stck Ticker60705V103 | Stock NameMOBIA MED INC | $ Position$10,696,979 | % Position2.00% | $ Change | # Change |